Explore the potential role of EYLEA® 8mg in RVO management as leading experts discuss the QUASAR data and its implications for real‑world clinical practice, featuring insights from Professor Varun Chaudhary and Professor Richard Gale.
This video is produced and fully funded by Bayer, and intended for healthcare professionals only
Expert retina specialists discuss the efficacy and safety data of the ranibizumab biosimilar, SB11, and explore the practical implications of biosimilars in the broader real-world context.
Rishi P. Singh, MD, highlights various treatment options available for the management of patients with age-related macular degeneration, as well as the status of potential therapies.